Phytochemicals as Dynamic Surface Ligands To Control Nanoparticle–Protein Interactions
Open Access
- 22 February 2018
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 3 (2) , 2220-2229
Abstract
The rapid formation of the protein corona on to the nanoparticle (NP) surface is the key that confers biological identity to NPs and subsequently dictates their fate both in vitro and in vivo. Despite significant efforts, the inability to control the spontaneous interaction of serum proteins with the administered NPs remains a major constraint in clinical translation of nanomedicines. The ligands present on the NP surface offer promise in controlling their biological interactions; however, their influence on the NP–protein interaction is not well-understood. The current study investigates the potential of phytochemical-capped silver nanoparticles (AgNPs) toward allowing a control over NP interactions with the human serum albumin (HSA), the most abundant protein in the biological fluids. Specifically, we demonstrate the ability of curcumin (Cur) and epigallocatechin-3-gallate (EGCG) to independently act as reducing agents to produce phytochemical-capped AgNPs that show biologically desirable interactions with HSA. The key finding of our study is that the phytochemical-capped AgNPs initially interact with HSA more strongly compared to the citrate-stabilized AgNPs; however, the resultant NP–HSA complexes are less stable in the case of the former, which causes a lesser degree of changes in the protein conformation during interactions. Further, the choice of the phytochemical allows control over NP–HSA interactions, such that Cur- and EGCG-capped AgNPs interacted with HSA in a static versus dynamic manner, respectively. The diversity of the functional groups present in natural phytochemicals and their potential as in situ capping ligands during synthesis offer new opportunities in controlling the interactions of NPs with complex biological fluids, with implications in nanodiagnostics and nanomedicine.Keywords
Funding Information
- Australian Research Council (DP170103477, LP130100437, FT140101285)
- Maxwell Eagle Endowment Fund
This publication has 40 references indexed in Scilit:
- The Spectral Properties of (-)-Epigallocatechin 3-O-Gallate (EGCG) Fluorescence in Different Solvents: Dependence on Solvent PolarityPLOS ONE, 2013
- Laminin receptor specific therapeutic gold nanoparticles ( 198 AuNP-EGCg) show efficacy in treating prostate cancerProceedings of the National Academy of Sciences, 2012
- Palladium Complex Containing Curcumin as Ligand: Thermal and Spectral CharacterizationAmerican Journal of Chemistry, 2012
- Deviation from van't Hoff dependence in RP‐LC induced by tautomeric interconversion observed for four compoundsJournal of Separation Science, 2011
- Sensing of proteins in human serum using conjugates of nanoparticles and green fluorescent proteinNature Chemistry, 2009
- A quantitative fluorescence study of protein monolayer formation on colloidal nanoparticlesNature Nanotechnology, 2009
- Nanoparticle size and surface properties determine the protein corona with possible implications for biological impactsProceedings of the National Academy of Sciences of the United States of America, 2008
- Interaction of (−)‐epigallocatechin‐3‐gallate with human serum albumin: Fluorescence, fourier transform infrared, circular dichroism, and docking studiesProteins: Structure, Function, and Bioinformatics, 2006
- Probing BSA Binding to Citrate-Coated Gold Nanoparticles and SurfacesLangmuir, 2005
- Synthesis of Aqueous Au Core−Ag Shell Nanoparticles Using Tyrosine as a pH-Dependent Reducing Agent and Assembling Phase-Transferred Silver Nanoparticles at the Air−Water InterfaceLangmuir, 2004